M

MBX Biosciences, Inc.

18 employees

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Wellness

Date founded

2019

Funding rounds raised

Total raised

$115M

from 8 investors over 8 rounds

M

MBX Biosciences, Inc. raised $115M on November 14, 2022

Investors: Wellington Management, RA Capital Management, L.P., Norwest Venture Partners and OrbiMed Advisors

M

MBX Biosciences, Inc. raised $35M on July 27, 2020

Investors: BioCrossroads, OrbiMed Advisors, Frazier Healthcare Partners and Indiana Philanthropic Venture Fund (IU PhV)

FAQ